Tag Archives: Emerging Companies

Small Biotech Companies and China: 5 Keys to Success

BIO CEO

Big pharmaceutical countries aren’t the only ones investing in China. Emerging and mid-sized biotech companies are also exploring ways to enter China’s lucrative market and maximize their investment in the country. With limited resources, how can smaller companies operate efficiently and give Chinese patients access to their innovative products? A panel of experts explored these questions at the 2013 BIO CEO & Investor Conference. Jimmy Zhang from Merck moderated a panel including: Friedhelm Blobel, PhD, President, CEO, Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Biotech Hall of Fame: Interview with Biotech’s First Investment Banker

Biotech Hall of Fame

Earlier this week, I had the opportunity to discuss biotech’s storied history with Fred Frank, one of the industry’s greatest luminaries, on what we can learn from the past to help shape the future. Fred Frank, formerly Vice Chairman of both Lehman Brothers Inc. and Peter J. Solomon Company, recently became Vice Chairman of Burrill & Company and Chairman of Burrill Securities, the broker dealer arm of Burrill & Company. He was the first life Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Small Companies, Big Returns

The broader biotech indices are up more than 30 percent this year and have reached levels not seen since the peak of March 2000. Larger biotechs account for much of the index returns, as we have described previously, and have helped the sector outperform the S&P 500 by two fold. But how have smaller biotech companies been performing? As of Nov 30, 27 companies that started the year under $1 billion in market capitalization have Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

2012 BIO Investor Forum: Looking Ahead to Investment Opportunities

partnering1

The biggest biotech news out of Washington in recent months was the Jumpstart Our Business Startups (JOBS) Act, which passed Congress overwhelmingly and was signed into law by President Obama in April.  For those not familiar, the JOBS Act creates a new category of issuers, called “emerging growth companies” (EGCs), which is defined as newly public companies with than $1 billion in annual revenues and a public float below $700 million. EGCs are given a Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

2012 BIO International Convention: Q&A with Progenika

Progenika

In anticipation of the 2012 BIO International Convention we spoke with Progenika, a newly established Spanish healthcare company, to get their perspective on the event. Progenika develops, produces, and commercializes tools for the diagnosis and prognosis of diseases and for predicting response to drug treatment. Read on to learn more about this innovative company. 1) Progenika is a newly established company that has created new subsidiaries; it has internationalized and brought products to the market Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,